Indoco Remedies Ltd banner

Indoco Remedies Ltd
NSE:INDOCO

Watchlist Manager
Indoco Remedies Ltd Logo
Indoco Remedies Ltd
NSE:INDOCO
Watchlist
Price: 189.35 INR 1.11% Market Closed
Market Cap: ₹17.5B

Net Margin

-6.5%
Current
Declining
by 7.1%
vs 3-y average of 0.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-6.5%
=
Net Income
₹-1.1B
/
Revenue
₹17.6B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-6.5%
=
Net Income
₹-1.1B
/
Revenue
₹17.6B

Peer Comparison

Country Company Market Cap Net
Margin
IN
Indoco Remedies Ltd
NSE:INDOCO
17.5B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
879.7B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
232B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
295.2B USD
Loading...
CH
Novartis AG
SIX:NOVN
236.4B CHF
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
154.1B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
116.1B USD
Loading...

Market Distribution

Lower than 88% of companies in India
Percentile
12th
Based on 5 531 companies
12th percentile
-6.5%
Low
-305 007.7% — 2.1%
Typical Range
2.1% — 11.6%
High
11.6% — 1 221 633.3%
Distribution Statistics
India
Min -305 007.7%
30th Percentile 2.1%
Median 5.8%
70th Percentile 11.6%
Max 1 221 633.3%

Indoco Remedies Ltd
Glance View

Market Cap
17.5B INR
Industry
Pharmaceuticals

Indoco Remedies Ltd. engages in manufacturing and marketing of Formulations (Finished Dosage Forms) and active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-01-07. The firm is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The firm's geographical segments include India and Outside India. The firm has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.

INDOCO Intrinsic Value
LOCKED
Unlock
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-6.5%
=
Net Income
₹-1.1B
/
Revenue
₹17.6B
What is Indoco Remedies Ltd's current Net Margin?

The current Net Margin for Indoco Remedies Ltd is -6.5%, which is below its 3-year median of 0.7%.

How has Net Margin changed over time?

Over the last 3 years, Indoco Remedies Ltd’s Net Margin has decreased from 9.5% to -6.5%. During this period, it reached a low of -6.7% on Jun 30, 2025 and a high of 9.5% on Dec 31, 2022.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett